ADMA Biologics Inc Cash Flow Reinvestment Rate
ADMA Biologics Inc cash flow reinvestment rate. ADMA Biologics Inc (ADMA) has a Cash Flow Reinvestment Rate of 0.08x as of June 2026, reinvesting $2.26 Million (capex $2.26 Million ) from operating cash flow of $29.54 Million. Explore ADMA Biologics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ADMA Biologics Inc (2023–2025)
Cash flow reinvestment rate of ADMA Biologics Inc from 2023 to 2025. Historical reinvestment intensity for ADMA Biologics Inc across 3 annual periods. Explore ADMA Biologics Inc (ADMA) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
ADMA Biologics Inc Cash Flow Reinvestment Rate by Year (2023–2025)
ADMA Biologics Inc cash flow reinvestment rate by year from 2023 to 2025. Year-by-year capital reinvestment analysis for ADMA Biologics Inc. For the full cash flow conversion analysis, see ADMA Biologics Inc (ADMA) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.45x | $22.57 Million | $50.40 Million | $22.57 Million | ▲ +210.0% |
| 2024 | 0.14x | $17.15 Million | $118.67 Million | $8.57 Million | ▼ -89.7% |
| 2023 | 1.40x | $12.30 Million | $8.80 Million | $4.98 Million | — |